ACF
LIVE

Serial Number

87619924

Owner

Pfanstiehl, Inc.

Attorney

Paul C. Llewellyn

First Use Date

Aug 31, 2020

Filing Date

Sep 23, 2017

Add to watchlist:

No watchlists yet
View on USPTO

ACF Trademark

Serial Number: 87619924 • Registration: 6266965

ACF is a trademark filed by Pfanstiehl, Inc. on September 23, 2017. The trademark is classified under Class 1 (Chemicals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Pfanstiehl, Inc. (32 trademarks)

Waukegan, IL 60085

Entity Type: 03

Trademark Details

Filing Date

September 23, 2017

Registration Date

February 9, 2021

First Use Anywhere

August 31, 2020

First Use in Commerce

August 31, 2020

Published for Opposition

September 11, 2018

Goods & Services

Biochemical research and development; Chemical, biochemical, biological and bacteriological research and analysis; Drug discovery services; Pharmaceutical drug development services; Product research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines

Chemicals and biochemicals for use in the formulation, development and manufacture of pharmaceuticals, biopharmaceuticals, vaccines, finished drug products, parenteral drugs and therapies; Chemicals and biochemicals for use in biotechnological product development and manufacturing processes; excipients and active ingredients for use in development, formulation and manufacture of pharmaceuticals, biopharmaceuticals, vaccines, injectable formulations, pharmaceutical intermediaries and drug formulations; chemicals, biochemicals, stabilizers, catalysts, enzymes, formulation ingredients, additives, drug delivery molecules and carriers, and buffers, all for use in the pharmaceutical and biopharmaceutical industry; active pharmaceutical ingredients for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products; formulation ingredients, additives, drug delivery molecules, and carriers, and buffers, all for use in the pharmaceutical and biopharmaceutical industry; pharmaceutical intermediates for use in the pharmaceutical and biopharmaceutical industry; biochemical excipients for use in the pharmaceutical and biopharmaceutical industry; biochemical catalysts; biochemical preservers and protectors for use in the pharmaceutical and biopharmaceutical industry

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 9, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
Feb 9, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 6, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 5, 2021 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 2, 2020 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Dec 1, 2020 SUPC
SOU EXTENSION 5 GRANTED
Dec 1, 2020 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 1, 2020 AITU
USE AMENDMENT FILED
Nov 17, 2020 IUAF
SOU EXTENSION 5 FILED
Nov 17, 2020 EXT5
SOU TEAS EXTENSION RECEIVED
Nov 17, 2020 EEXT
TEAS STATEMENT OF USE RECEIVED
Nov 17, 2020 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 10, 2020 EXRA
SOU EXTENSION 4 GRANTED
Nov 6, 2020 EX4G
SOU EXTENSION 4 FILED
Nov 6, 2020 EXT4
SOU TEAS EXTENSION RECEIVED
Nov 6, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 7, 2020 EXRA
SOU EXTENSION 3 GRANTED
May 5, 2020 EX3G
SOU EXTENSION 3 FILED
May 5, 2020 EXT3
SOU TEAS EXTENSION RECEIVED
May 5, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 7, 2019 EXRA
SOU EXTENSION 2 GRANTED
Nov 5, 2019 EX2G
SOU EXTENSION 2 FILED
Nov 5, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 5, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 13, 2019 EXRA
SOU EXTENSION 1 GRANTED
Apr 11, 2019 EX1G
SOU EXTENSION 1 FILED
Apr 11, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 11, 2019 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 6, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 11, 2018 NPUB
PUBLISHED FOR OPPOSITION
Sep 11, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 22, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 7, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 16, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 16, 2018 CRFA
ASSIGNED TO LIE
Jul 13, 2018 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 29, 2018 TCCA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 29, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 30, 2017 GNRN
NON-FINAL ACTION E-MAILED
Dec 30, 2017 GNRT
NON-FINAL ACTION WRITTEN
Dec 30, 2017 CNRT
ASSIGNED TO EXAMINER
Dec 29, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 28, 2017 NWOS
NEW APPLICATION ENTERED
Sep 27, 2017 NWAP